Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06097234 · ClinicalTrials.gov registry record · NA
Comparison of Virtual Pelvic Floor Physical Therapy With a Pelvic Floor Trainer in the Treatment of Stress Urinary Incontinence.
A NA study of Stress Urinary Incontinence and Pelvic Floor Disorders, sponsored by Pelex.
- Recruiting
- Registry status
- NA
- Development phase
- 45
- Enrollment target
- 1
- Study location
NCT06097234: Recruiting NA study of Stress Urinary Incontinence and Pelvic Floor Disorders, sponsored by Pelex.
NCT06097234 is a NA study of Stress Urinary Incontinence and Pelvic Floor Disorders that is actively recruiting participants, run by Pelex. The registered enrollment target is 45 participants, below the 161-participant average among 35 other Stress Urinary Incontinence trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06097234, a NA study of Stress Urinary Incontinence and Pelvic Floor Disorders, is actively recruiting participants, sponsored by Pelex.
- RECRUITING
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to compare the efficacy of the electromyography component of the company's pelvic health product in a patient population with stress urinary incontinence to treatment with pelvic floor physical therapy. The main questions it aims to answer are: Does treatment with the device under study improve symptoms of stress urinary incontinence as measured by the ICIQ when compared to pelvic floor physical therapy? Does treatment with the device under study combined with pelvic floor physical therapy improve symptoms of stress urinary incontinence as measured by the ICIQ when compared to pelvic floor physical therapy alone and treatment with the device alone? Participants will be given one of three treatments: 1. The devices under study alone 2. The device under study plus 4 weekly visits with a pelvic floor physical therapist 3. Four weekly visits with a physical therapist alone Participants will perform a standardized pelvic floor muscle training program 10 minutes a day, four times a week for 4 weeks. There will be a mid-study check in to assure all devices are functioning appropriately. At the end of the study, participants will complete a post-treatment urinary incontinence symptom questionnaire(ICIQ).
Conditions Studied
Interventions
- DEVICE Pelex Upp
- BEHAVIORAL Pelvic Floor Physical Therapy
Study Locations (1)
New York
- Pelex - Little Neck
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2024-01-01 |
| Est. Completion | 2024-07-01 |
| Phase | NA |
What NCT06097234 shows while recruiting
NCT06097234 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 161-participant average among 35 other Stress Urinary Incontinence trials with a reported enrollment target (72% lower).
The record links to 2 conditions, with Stress Urinary Incontinence appearing as the primary indexed condition, and to 2 interventions - of which Pelex Upp is the first listed.
NCT06097234 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06097234 about?
NCT06097234 is a clinical study titled "Comparison of Virtual Pelvic Floor Physical Therapy With a Pelvic Floor Trainer in the Treatment of Stress Urinary Incontinence.". The goal of this clinical trial is to compare the efficacy of the electromyography component of the company's pelvic health product in a patient population with stress urinary incontinence to treatment with pelvic floor physical therapy. The main questions it aims to answer are: Does treatment wit...
What is the current status of trial NCT06097234?
This trial is currently recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2024-01-01. Estimated completion is 2024-07-01.
What conditions does trial NCT06097234 study?
This clinical trial studies the following conditions: Stress Urinary Incontinence, Pelvic Floor Disorders.
What interventions are being tested in trial NCT06097234?
The interventions under investigation include: Pelex Upp (DEVICE), Pelvic Floor Physical Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT06097234?
This trial is sponsored by Pelex, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06097234 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stress Urinary Incontinence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06097234's enrollment target sits among peer trials
45 31st of 35 higher than 5 of 35 other Stress Urinary Incontinence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stress Urinary Incontinence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
ProACT Post-Approval Study
RECRUITING · NA
-
Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence
RECRUITING · NA
-
Impact of Unrestrictive Exercise Following Mid-Urethral Sling Surgery
RECRUITING · NA
-
Single-incision Versus Retropubic Mid-Urethral Sling (Solyx) for SUI During Minimally Invasive Sacrocolpopexy
RECRUITING · NA
-
BELIEVE Trial: Bulking vErsus sLing for Treating Stress Urinary IncontinEnce at the Time of Vaginal prolapsE Repair (BELIEVE)
RECRUITING · NA
-
Effect of Peri-Urethral Stimulation on Intra-Urethral Pressure
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI